SUCRES

Hybrid selective conversion of carbon dioxide into carbohydrates

Biomolécule

Context

Carbohydrates—ranging from structural polysaccharides to biologically active oligosaccharides—include a subset of ‘rare sugars’ that possess high pharmaceutical relevance because of their signaling roles. However, these rare carbohydrates are presently produced using fossil-derived precursors, and there currently is no viable route based on renewable carbon sources.

Objectives

The objective of this project is to propose a synthetic pathway for rare carbohydrates and their derivatives from renewable carbon. Based on CO₂ conversion, this synthetic route employs a cascading process combining organometallic catalysis with enzymatic catalysis.

Expected results

The goal is to develop an industrially scalable synthetic route for rare carbohydrates derived from CO₂ conversion.

Target markets

  • Health

Components involved

  • UMR 792 TBI
  • CRITT Bio-Industries
  • UPR 8241 LCC
Full cost
0 k€
Launch year
0
Month
0